Advertisement
World
Common antidepressant may help adults with long COVID: study
April 2, 2026
Global News
Scroll
The clinical trial showed a 99 per cent probability that fluvoxamine outperformed placebo for 'reducing fatigue severity and improving quality of life in people with long COVID.'
Global News
Coverage and analysis from Canada. All insights are generated by our AI narrative analysis engine.
Canada
Bias: center
Advertisement